Loading…
Wednesday April 30, 2025 4:15pm - 5:00pm PDT
Dive into the therapeutic areas and innovation pipelines shaping the biotech industry’s current deal-making priorities, and uncover how companies are positioning themselves for scalable success.

  • Examine how therapeutic advancements in oncology, neurology, and rare diseases are influencing deal-making.
  • Explore the role of precision medicine and emerging modalities in shaping partnership priorities.
  • Learn how biotechs are leveraging R&D pipelines to create competitive differentiation.


Speakers
avatar for Chris DeRespino

Chris DeRespino

Chief Business Officer, 3T Biosciences
Chris DeRespino serves as chief business officer at 3T Biosciences, an industry leader in pHLA targeting biologics and target discovery. In this role, Mr. DeRespino is responsible for leading G&A functions including business development, finance & human resources. Previously, Mr... Read More →
avatar for Elaine Cheung

Elaine Cheung

Chief Business Officer, Moonwalk Bio
avatar for David Brower

David Brower

Chief Business Officer, Accent Therapeutics
avatar for Dan Oliver

Dan Oliver

CEO & Co-Founder, Rejuvenate Bio
Wednesday April 30, 2025 4:15pm - 5:00pm PDT
Town & Country Resort

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link